Literature DB >> 18753464

Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.

Jorge I F Salluh1, Fernando A Bozza2, Márcio Soares3, Juan Carlos R Verdeal4, Hugo C Castro-Faria-Neto5, José Roberto Lapa E Silva6, Patrícia T Bozza3.   

Abstract

BACKGROUND: High cortisol levels are frequent in patients with severe infections. However, the predictive value of total cortisol and of the presence of critical illness-related corticosteroid insufficiency (CIRCI) in severe community-acquired pneumonia (CAP) remains to be thoroughly evaluated. The aim of this study was to investigate the predictive value of adrenal response in patients with severe CAP admitted to the ICU.
METHODS: Baseline and postcorticotropin cortisol levels C-reactive protein (CRP), d-dimer, clinical variables, sequential organ failure assessment (SOFA), APACHE (acute physiology and chronic health evaluation) II, and CURB-65 (confusion, urea nitrogen, respiratory rate, BP, age > or = 65 years) scores were measured in the first 24 h. Results are shown as median (interquartile range [IQR]). The major outcome measure was hospital mortality.
RESULTS: Seventy-two patients with severe CAP admitted to the ICU were evaluated. Baseline cortisol levels were 18.1 microg/dL (IQR, 14.4 to 26.7 microg/dL), and the difference between baseline and postcorticotropin cortisol after 250 microg of corticotropin was 19 microg/dL (IQR, 12.8 to 27 microg/dL). Baseline cortisol levels presented positive correlations with scores of disease severity, including CURB-65, APACHE II, and SOFA (p < 0.05). Cortisol levels in nonsurvivors were higher than in survivors. CIRCI was diagnosed in 29 patients (40.8%). In univariate analysis, baseline cortisol, CURB-65, and APACHE II were predictors of death. The discriminative ability of baseline cortisol (area under receiver operating characteristic curve, 0.77; 95% confidence interval, 0.65 to 0.90; best cutoff for cortisol, 25.7 microg/dL) for in-hospital mortality was better than APACHE II, CURB-65, SOFA, d-dimer, or CRP.
CONCLUSIONS: Baseline cortisol levels are better predictors of severity and outcome in severe CAP than postcorticotropin cortisol or routinely measured laboratory parameters or scores as APACHE II, SOFA, and CURB-65.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753464     DOI: 10.1378/chest.08-1382

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Severe community-acquired pneumonia and PIRO: a new paradigm of management.

Authors:  Jordi Rello; Thiago Lisboa; Richard Wunderink
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

3.  Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective study.

Authors:  Kensuke Suzuki; Tomomi Ichikawa; Hideaki Furuse; Takeshi Tsuda; Kotaro Tokui; Yasuaki Masaki; Seisuke Okazawa; Kenta Kambara; Minehiko Inomata; Toru Yamada; Toshiro Miwa; Shoko Matsui; Tatsuhiko Kashii; Hirokazu Taniguchi; Ryuji Hayashi; Kazuyuki Tobe
Journal:  Support Care Cancer       Date:  2014-12-30       Impact factor: 3.603

4.  Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?

Authors:  Marco Confalonieri; Djillali Annane; Caterina Antonaglia; Mario Santagiuliana; Ediva M Borriello; G Umberto Meduri
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 5.  Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections.

Authors:  Manuela Nickler; Manuel Ottiger; Christian Steuer; Andreas Huber; Janet Byron Anderson; Beat Müller; Philipp Schuetz
Journal:  Respir Res       Date:  2015-10-15

Review 6.  Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis.

Authors:  Jirui Bi; Jin Yang; Ying Wang; Cijiang Yao; Jing Mei; Ying Liu; Jiyu Cao; Youjin Lu
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

Review 7.  Biomarkers in community-acquired pneumonia: a state-of-the-art review.

Authors:  Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Sanvicente; Elyara F Pacheco; Karoline Dalla Rosa
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

8.  Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia.

Authors:  Motoi Ugajin; Kenichi Yamaki; Natsuko Hirasawa; Takanori Kobayashi; Takeo Yagi
Journal:  Int J Gen Med       Date:  2013-08-20

9.  Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial.

Authors:  Claudine A Blum; Nicole Nigro; Bettina Winzeler; Isabelle Suter-Widmer; Philipp Schuetz; Matthias Briel; Roland Bingisser; Werner Zimmerli; Elke Ullmer; Hanno Elsaesser; Philip Tarr; Sebastian Wirz; Robert Thomann; Eveline Hofmann; Nicolas Rodondi; Hervé Duplain; Dieter Burki; Beat Mueller; Mirjam Christ-Crain
Journal:  Trials       Date:  2014-06-28       Impact factor: 2.279

Review 10.  Prognostic scores and biomarkers for pediatric community-acquired pneumonia: how far have we come?

Authors:  Samuel N Uwaezuoke; Adaeze C Ayuk
Journal:  Pediatric Health Med Ther       Date:  2017-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.